论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
病例报告:粪便微生物群移植治疗 COVID-19 疫苗接种后发生的全身性湿疹
Authors Huang T, Lv Y, Wang W, Chen Y, Fan L, Teng Z, Zhou X, Shen H, Fu G
Received 7 October 2023
Accepted for publication 9 January 2024
Published 26 January 2024 Volume 2024:17 Pages 229—235
DOI https://doi.org/10.2147/CCID.S443542
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Jeffrey Weinberg
Abstract: Adverse skin reactions caused by the COVID-19 vaccine have attracted considerable attention. As we all know, the development mechanism of some skin diseases is related to the gut and skin microbiome. A 78-year-old male patient who received the COVID-19 vaccine developed generalized eczema with multiple dense black patches over the body, a widespread rash, erosion, and scabs on his limbs, as well as facial edema. The patient experienced recurrent flare-ups after conventional treatment, but then recovered well without recurrence after undergoing three fecal microbial transplantation (FMT) treatments. This rare case is reported for the first time in this study. This report demonstrates the possible potential of FMT in targeting refractory skin diseases, such as eczema, as well as diseases associated with gut microbiota disturbance after vaccination.
Keywords: FMT, eczema, COVID-19 vaccine